People | September 20, 2024
Shilpa Biologicals appoints Dr. Sridevi Khambhampaty as CEO
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
ALS patients experience neuroinflammation and rapid neurodegeneration
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Konieczny has served as Interim CEO since April 2024
Finerenone is the first mineralocorticoid receptor (MR) antagonist to demonstrate definitive cardiovascular benefits in a Phase III study in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ?40%
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
Subscribe To Our Newsletter & Stay Updated
